What's New in Research Funding

Molecular structuresPage last updated May 11, 2021

We are pleased to assist the research community in identifying potential sources of funding through the provision of information posted here:

  • All Applicants submitting through the University of Toronto MUST have submitted their application information online via the My Research Applications (MRA) portal. This is an online submission process to obtain institutional approval on research applications. Please note that you will be required to upload a copy of the application to this online submission. Please complete this step as early as possible and at least several days ahead of the deadline to insure all approvals are obtained on time. Please visit the OVPRI's MRA webpage for complete information on this process.
  • Please note, all grants requiring the Dean's signature should be brought to the Faculty of Medicine Research Office in the C. David Naylor Building, Suite 119, 6 Queen’s Park Cres W. to the attention of Cindy Faber cindy.faber@utoronto.ca.
  • Also, our office offers a grant editing service for researchers submitting proposals to tri-council or any other funding agency. For more information, please contact golnaz.farhat@utoronto.ca..
  • Recently received news and updates are posted below and sent via email to our LISTSERV. To join click here.

Comprehensive funding opportunities may be searched through these links:

 

Recently Received News and Update

May 12, 2021

  • Save the Date! Temerty Faculty of Medicine Annual Grant Writing Workshop.
    9:05am                       Opening Remarks
                                          Professor Justin Nodwell, PhD, Vice Dean, Research and Graduate Education
    9:10am                        Overview of Services, Office of the Vice-Dean, Research & Innovation
                                          Jeremy Knight, Director
    9:30am                       A Reviewer’s Perspective on Grant Review Panels and Funding Success
                                          Professor Tania Watts, PhD, Department of Immunology and University of Toronto CIHR Delegate
    10:00am                      Q&A – 15 minutes
    10:15am                      Core Facilities and Services in the Faculty of Medicine
                                           Natasha Christie-Holmes, PhD, Research Operations Officer
    10:35am                      Grant Fundamentals and How to Write a Persuasive Research Proposal
                                           Golnaz Farhat, PhD, Grants and Awards Editor
    Date: June 23, 2021 from 9am - 11:30am.

  • How to Write a Successful Banting Postdoctoral Fellowship Application. The Research and Graduate Education Office will be hosting its inaugural Banting Postdoctoral Fellowship Information Session on How to Write a Successful Banting Postdoctoral Fellowship Application for all UofT Temerty Faculty of Medicine postdoctoral researchers. This year Golnaz Farhat, Grants and Awards Editor, and Dr. Vito Hugo Balasco Serrão, Banting Postdoctural Fellow, will be speaking. Also, opening remarks will be made by Dr. Justin Nodwell, Vice Dean, Research and Graduate Education
    For more information about the 2021-22 Banting Postdoctoral program at the Temerty Faculty of Medicine, visit our webpage here.
    Registration: visit here!
    Please note: Zoom details will be provided a few days before the event.
    Date: June 15, 2021 from 12:00pm - 2:00pm

  • Mitacs Elevate is now accepting applications for postdoc funding The call for proposals is now open! Mitacs Elevate is now accepting proposal submissions for two years of postdoc funding valued at $60,000/year plus extensive customized professional development training ($7,500/year non-cash value).
    Key deadlines:
    • June 2, 2021 — If applicable, deadline to submit not-for-profit eligibility check or conflict of interest declaration at 5 p.m. PT
    • June 30, 2021 — Deadline to submit full application at 5 p.m. PT

  • Aplastic Anemia & MDS International Foundation, Inc. (AA&MDSIF): Research Grants Program. The Aplastic Anemia and MDS International Foundation, Inc. (AAMDSIF) is pleased to help researchers dedicated to the study of bone marrow disorders, advance the understanding, prevention and treatment of the following bone marrow disorders in both pedriatric and adult populations:Successful applicants can be funded up to $60,000 for two years ($30,000 each year, with second-year funding pending approved progress in the first year). Deadline for LOIs: June 30, 2021; Application deadline: October 16, 2021.

  • A-T Children's Project: Research Grant Program.Their greatest interest is in funding translational and clinical research projects, particularly those projects focused on the neurological problems faced by all patients with A-T. They are desperate to deliver new ideas from A-T research with practical relevance for patients into the hands of experts involved in drug discovery and clinical development. They have interest in disease-modifying strategies that would prevent, slow, or stop the progression of the disease as well as symptom-improving strategies that address neural circuit function, immune system health and lung function. One- and two-year proposals are funded up to a maximum total direct cost of US $75,000 per year. Short-term "bridge funding" may very rarely be provided to investigators who are applying for funding from other sources such as the NIH and need interim support while generating preliminary data necessary for their application. We limit this bridge funding support to a maximum of $50,000 and one year. Deadline for LOIs: July 1, 2021, Deadline for full applications: September 1, 2021.

 

May 3, 2021

  • Announcing the TC3 Fellows Program. The TC3 Fellows Program was established to provide financial support for outstanding trainees (MSc, PhD, Postdoc) working on interdisciplinary, collaborative cannabis and cannabinoid-related projects in TC3 member research groups across the University of Toronto and the Toronto Academic Health Sciences Network. Funding Amount: $10,000 (Graduate Students) and $30,000 (Postdoctoral Fellows). Deadline: May 25, 2021 at noon. 

  • Join us at the TC3 Launch Research & Networking Symposium. This symposium will bring together cannabis and cannabinoid researchers and trainees from the University of Toronto and Toronto Academic Health Sciences Network and will provide an opportunity to network, seek new collaborations, build links and share health research findings related to cannabis and cannabinoids. Featuring short talks and a panel session, this research and networking symposium will serve as a platform to highlight our local ecosystem's cannabis and cannabinoid research assets from plant all the way to policy and everything in between. Register now.

  • Temerty Knowledge Translation Grant: Addressing health inequities in disadvantaged populations. We are pleased to announce the 2nd round of the Temerty Knowledge Translation Grant Program to fund collaborative projects led by Temerty Medicine faculty members working with community organizations to address health inequities.  A total of $250,000 is available in this round to fund 1-year grants of up to $100,000. The competition is open to full-time Temerty Medicine faculty members on campus and at hospital-based research institutes affiliated with the University of Toronto. Deadline for submission: June 15, 2021.

  • 2021 OBIO Business Development Skills Program. OBIO’s Business Development Skills Program provides funding to scaling companies of all sizes to increase their business development bench strength. The program supports companies as they build and enhance critical capabilities in-house by providing mentorship and training for key team members. With OBIO’s health science industry support, employers are able to be more successful in securing ‘sticky’ capital from global investors to grow their businesses and create new jobs. OBIO's goal is for health science companies to grow in Ontario, stay in Ontario and be leaders in the global market. Application deadline: May 28, 2021.

  • The Huntington Society of Canada is pleased to launch the 2021 NAVIGATOR. The long standing Navigator Research Program supports HD researchers across Canada. This program supports basic scientific research of direct and immediate relevance to Huntington Disease in Canada with the aim of providing a platform for the recruitment of outstanding investigators to HD research, to facilitate research collaboration nationally and internationally, and to support research that is relevant to other neurodegenerative disorders.  Deadline for LOIs: May 31, 2021, Deadline for invited full applications: July 9, 2021.

 

April 14, 2021

  • Online questionnaire for CIHR research community.  Dr. Michael Strong, CIHR President, will engage with representatives of the University of Toronto leadership and research community in a virtual meeting in May. In advance of his virtual visit, we are providing the CIHR research community an opportunity to share their comments on some pressing issues available through a questionnaire that we have posted online for your convenience. You can access and complete the questionnaire at: CIHR May 2021 QuestionnaireWe ask that you kindly provide your responses no later than 5 pm on Friday, April 23rd, 2021. After the questionnaire closes, we will review and summarize responses and develop feedback for Dr. Strong. Please contact Drew Gyorke if you have any questions at: drew.gyorke@utoronto.ca

  • NIH New Workshop. This session will feature NIH Program Officer, Dr. Dona Love, to provide insights on NIH funding opportunities and the application and peer-review processes. The session will also welcome a panel of campus - and hospital-based researchers who have demonstrated a history of success with NIH proposals. Panelists will share insights, including the intricacies of the NIH peer review process, and also discuss practical tips and strategies that faculty can engage in to enhance their chances of success. Date: May 3, 2021, 2:30pm-4:00pm

  • Fighting Blindness Canada The goal of the 2021 Research Grant Competition is to fund research that advances Fighting Blindness Canada’s mission to accelerate the development and availability of treatments and cures for blinding eye diseases. The program allows applications from all areas of vision research. The program is open to independent investigators and/or research teams with a principal investigator from a Canadian institution and provides a budget of up to $100,000 a year for up to two years. Deadline for Letters of Intent: April 29, 2021, Full applications due July 22, 2021.
     
  • NSERC Alliance and Mitacs Accelerate streamlined funding opportunity now available NSERC and Mitacs are pleased to build on the success of their existing partnership with a new joint initiative that will support the R&D efforts of Canadian university researchers and their partners, while supporting highly qualified personnel including students and/or postdoctoral fellows. Through NSERC’s Alliance grants and Mitacs’s Accelerate, this new opportunity is available to Canadian researchers through a single application submission and review process. Applicants are invited to include in their Alliance application a request for additional support through Mitacs Accelerate internships as a component of the training of highly qualified personnel.
     
  • Huntington's Disease Society of America (HDSA): HD Human Biology Project: The Human Biology Project was launched in 2013 with the goal of fostering innovative research in collaboration with HD clinics to better understand the biology of Huntington’s disease as it occurs in humans. HDSA encourages researchers to consider one of HDSA’s 54 Centers of Excellence as a potential collaborator, but applicants may propose to work with any HD clinic around the world. Upper amount: $150,000 USD.  Deadline for Letters of Intent: May 7, 2021; Application deadline: July 9, 2021.

March 23, 2021

  • Simons Foundation Autism Research Initiative2021 Pilot Grants. The focus of this program is to provide early support for exploratory ideas, particularly those with novel hypotheses. Appropriate projects for this mechanism include those considered higher risk but with the potential for transformative results. In particular, they encourage applications that propose research to link genetic or other ASD risk factors to molecular, cellular, circuit or behavioral mechanisms and set the stage for development of novel interventions. Pilot Awards Support innovative, high-risk, proposals requesting support for projects or early-stage experiments. The maximum budget is $300,000USD (including 20% indirect costs) for up to 2 years. Letter of Intent Deadline: May 6, 2021. Applicants will be notified if they will be invited to full proposal on July 1, 2021.

  • National Institutes of Health - Funding AnnouncementsThe National Institutes of Health has released the included requests for applications and program announcements.

  • Congressionally Directed Medical Research Programs - Funding Opportunities. US Department of Defense (DOD) Office of the Congressionally Directed Medical Research Programs (CDMRP) has released funding and pre-funding announcements for the following programs:
    Pre-Announcements:
    - Multiple Sclerosis Research Program (MSRP)
    - Lupus Research Program (LRP)
    Funding Announcements
    - Lung Cancer Research Program (LCRP)
    - Peer Reviewed Medical Research Program (PRMRP)
    - Gulf War Illness Research Program (GWIRP)
    Details on how to apply can be found here.
     
  • Myelodysplastic Syndromes Foundation: Young Investigator Grant. The purpose of this Young Investigator Grant is to provide an investigator the opportunity to initiate, continue or complete a project that focuses on either basic or clinical management into the causation, epidemiology, molecular biology, cytogenetics, morphology, prognosis and treatment of the Myelodysplastic Syndromes or related myeloid neoplasms. An investigator, US or International, that is 40 years old or less on the date of application submission is eligible. Upper amount: USD $100,000. Funding may be used towards salary support, technician support, supplies, equipment, travel, etc. necessary for the pursuit of the recipient’s research project. The grant period is from July 1, 2021 through June 30, 2023. Deadline for applications: April 30, 2021.
     
  • Action on Hearing Loss (Trading Name of the Royal National Institute for Deaf People ([RNID]). Translational Grant (TRIH Grant). The Translational Grant aims to support and accelerate the translation of research discoveries into potential new treatments to protect and regenerate hearing and /or silence tinnitus. It funds projects at both academic institutions and small/medium enterprises in any country. It supports:
    - research with a strong commercial potential that is likely to attract follow-on funding at the conclusion of the grant
    - studies that will facilitate and enable the progression of promising basic research towards testing in clinical trials.
    Applicants may be from any country and may be from academic institutions and small/medium enterprises. Grants are up to £100,000 per year, for up to three years. Indirect costs or the salaries of permanent employees will not be funded. Deadline for Expressions of Interest: April 9, 2021; Application deadline: June 11, 2021.

March 11, 2021

  • Simons Foundation Autism Research Initiative – Human Cognitive and Behavioral Science RFA. The Simons Foundation Autism Research Initiative is now accepting applications that address foundational knowledge about the neurobehavioral differences associated with autism spectrum disorders (ASD), which will directly inform the development or refinement of tools needed for translational efforts, such as biomarkers and outcome measures. Special emphasis is placed on objective, quantitative measures that may be used in conjunction with standardized clinical measures and genomic information to better triangulate phenotypic and neurobiological variability within and across individuals with ASD. Project budget must be for $750,000 or less, inclusive of 20 percent indirect costs, over a period of up to three (3) year. UofT Internal deadline: April 29, 2021; Sponsor deadline: May 3, 2021.
     

  • CIHR 2021 Institute Advisory Board (IAB) Membership Renewal Cycle. CIHR has launched the 2021 IAB membership cycle. Applications submitted online between now and April 12, 2021 will be considered for the 2021 cycle. During the selection process, each Institute will review the full list of candidates who submitted applications to their IAB to determine which candidates best fill the critical gaps created by turnover, both in expertise and in re-balancing demographic criteria (sex, language, career stage, and geographic and institutional representation). There will be a focus on ensuring that the IAB’s reflect the diversity of Canada and the health research ecosystem at large, and underrepresented groups are encouraged to apply to the open call. During this year’s membership cycle, the following Institutes are looking for new members to fill gaps (some gaps have been identified) on their IABs:

  • National MS Society - RFA: Detecting Multiple Sclerosis Before the Onset of Neurological Deficits.  The grants are awarded for 2 year for research project to support knowledge generation that will eventually lead to early detection of MS at the individual level multiple sclerosis. The maximum budget is $300,000 USD in direct costs. Town Hall & Q & A Webinar On Wednesday March 17, 2021, Noon EST NMSS will host a Town Hall webinar (register here) where their research staff will describe the intent of the RFA and answer questions. This session will be recorded and posted to the website. For this funding opportunity, a pre-application must be completed and submitted to the Society before the applicant can prepare a full application. Applicants are recommended to submit pre-applications well in advance of the pre-application due date. NMSS will provided notification of approval, disapproval, or the need for changes within two business days of pre-application submission. UofT Internal deadline: April 27, 2021 Full-applications sponsor deadline: April 30, 2021.

  • National Institutes of Health - Funding AnnouncementsThe National Institutes of Health has released the included requests for applications and program announcements.
     

  • MITO2 Inaugural Research Symposium. This research symposium with highlight the importance of mitochondrial medicine and introduce new and exciting areas for mitochondrial research.
    When: April 8th & 9th
    Event Details & Registration | Mitochondrial Innova (mito2i.ca)
     

  • Pfizer Global Medical Grants (GMG): Closing Knowledge Gaps in Osteoarthritis and Osteoarthritis Pain. Through this RFP, their intent is to support virtual and potentially live programs and other innovative digital medical education for HCPs. The focus is on Osteoarthritis and Chronic Pain associated with OA and patient-centered standard of care and management including pain and function, the biopsychosocial aspects of the disease, the complexities and challenges of care, and the future of OA/OA pain management. Programs targeted towards reviewing data at virtual or live osteoarthritis, rheumatology, pain, primary care, or other associated medical conferences, including but not limited to OARSI, EULAR, PAINWeek, AAFP, WCO, and ACR are of particular interest, as well as other meaningful education outside of congresses. The typical grant maximum under this RFP will be up to $200,000 USD. However, larger proposals may be considered for funding if they include a broad geographical scope and multiple activities. Deadline for applications: March 19 or June 18 or August 20, 2021.
     

  • Pfizer Global Medical Grants (GMG): Quality Improvement Grants to Support the Delivery of Gene Therapies to Patients with Rare Disease. Projects that will be considered for Pfizer support will focus on preparing and/or optimizing multidisciplinary care teams for the integration of gene therapy into the treatment armamentarium for patients with a Rare Disease. Support is available for the development of leadership, best practices, SOP development, site readiness, support and/or training of HCPs within a multidisciplinary team environment to optimize the quality of care for patients who have/will have gene therapy in their treatment armamentarium. Projects that address recombinant adeno-associated virus gene therapy in Rare Disease and are therapeutic area and disease area agnostic (i.e., platform) will be prioritized. Amount: Up to USD $50,000. Deadline for applications: June 1, 2021.
     

  • Cystic Fibrosis Foundation (CFF): Clinical Pilot and Feasibility Award. The intent of the Clinical Pilot and Feasibility Award is to enable investigators to collect sufficient preliminary data to determine the best strategies and methods for approaching a major question that ultimately will require assessment through a larger scale research and/or multi-center, collaborative clinical trial. Support may be requested for USD $80,000 annually (plus 12 percent for indirect costs) for up to two years. Deadline for Letters of Intent: March 19, 2021; Full application deadline: August 18, 2021.

 

March 1, 2021

 

February 11, 2021

  • CIHR Spring 2021 Project Grant competition update. Registration for the Spring 2021 CIHR Project Grant competition opened on February 4, 2021. Registration is due to CIHR by March 4, 2021 and full applications due to CIHR by April 1, 2021. Please find a detailed message from CIHR regarding some changes to the Spring 2021 Project Grant competition. Changes include: Revised Summary of Progress, Removal of Weighted Scores, Use of the Applicant Profile CV for Knowledge Users, Indigenous applicants and International applicants, and ensuring equitable access to research funds.

  • CIHR Spring 2021 Reviewer in Training programCIHR has announced the launch of the new Reviewer in Training (RiT) program for the Spring 2021 Project Grant competition. The RiT program expands on and replaces the Observer program to offer Early Career Researchers (ECRs) a learning opportunity to gain a better understanding of the elements of high quality review and the peer review process through direct participation in the Project Grant competition with the support of a Mentor. Applications to the RiT program may be submitted directly to CIHR prior to the application deadline. Full details including the link to apply online can be found here.
    Application deadline: February 26, 2021.

  • Pre-Announcement: CIHR Funding for SARS-CoV-2 Variant Research.  CIHR would like to provide the research community with information about the upcoming launch of a rapid research response, comprised of three separate but linked initiatives, designed to contribute to global efforts to address SARS-CoV-2 variants. 
    Initiative 1: Supplementary funding for CIHR funded COVID-19 researchers studying variants
    Initiative 2: Priority funding of applications focusing on SARS-CoV-2 variants
    Initiative 3: Funding of a Canadian Network of Networks for SARS-CoV-2 Variant Research
    Pre-announcement Informational Page: Web page with further information on the three initiatives, funding amounts and eligibility details.
     

  • 2021-23 Joint EMHSeed And XSeed Call For Proposals: Expanding research impact through inter-disciplinary collaboration. The Joint EMHSeed and XSeed is an interdivisional research funding program designed to promote multi-disciplinary research and catalyze new innovative partnerships between a coPI from the Faculty of Applied Science and Engineering (FASE) and a coPI from outside Engineering. Partner divisions for these programs are:
    -  For EMHSeed: Temerty Faculty of Medicine (FoM), UofT Affiliated Hospitals, Medicine by Design (MbD), Translational Biology and Engineering Program (TBEP)
    -  For XSeed: Faculty of Arts and Science (FAS), University of Toronto Mississauga (UTM), University of Toronto Scarborough (UTSC), Dalla Lana School of Public Health (DLSPH), as well as other UofT Divisions.Funding is available for a maximum of fifteen (15) new collaborative projects beginning in early September 2020. The budget for each Seed project will be $60,000 CAD/year for two (2) years. In exceptional cases, a no-cost extension for an additional year will be considered. The deadline for documentation is March 31, 2021 at 12:00 noon.

  • MITO2i Together With Its Partners Funds Innovative Projects Accelerating the Field of Mitochondrial Research. MITO2i is pleased to announce that 5 Innovation Grants, 2 Post-Doctoral Fellowships and 6 Graduate Student Scholarships will be awarded the funding. 

  • Pfizer Global Medical Grants (GMG):2021 Global ANGPTL3 ASPIRE. The intent of this Request for Proposal (RFP) is to support basic science, pre-clinical research and clinical research through a competitive grants program that advances medical knowledge of the role of ANGPTL3 in health and disease.0.Individual projects requesting up to USD $250,000 will be considered. Pfizer anticipates a total fund of USD $750,000. Research is expected to be completed and submitted for presentation/ publication within 3 years of
    Deadline for Letters of Intent: March 12, 2021; Full proposals due: July 2, 2021.
     

  • International Essential Tremor Foundation (IETF): ET Research Grants. The IETF is requesting proposals for grants addressing the nosology, etiology, pathogenesis, treatment or other topics relevant to essential tremor (ET).  In general, each IETF research grant will not exceed $50,000 each for a given year. Institutional indirect costs will not be provided. Deadline for applications: February 28, 2021.

January 28, 2021 

  • 2021 NSERC CREATE Information Webinar. NSERC’s Collaborative Research and Training Experience (CREATE) program awards grants of up to $1.65M over 6 years for the development of innovative training programs designed to enhance collaboration and facilitate the transition of trainees to productive employees in the Canadian workforce. In preparation for the next CREATE competition, NSERC will hold an information session via Cisco Webex webinar to provide an overview of the CREATE program and application process. The dates of the sessions are as follows:
    English session: February 4th 2021, 1:30 p.m. to 3:30 p.m. (ET)
    French session: February 5th 2021, 1:30 p.m. to 3:30 p.m. (ET)

    Registration is not necessary – anyone can connect using the link provided below.
    Webex: https://nsercvideo.webex.com/meet/guy.faubert
     

  • Spring 2021 Project Grant Competition: Ask Me Anything. CIHR will be hosting “Ask Me Anything” sessions designed to support participants and answer questions about the Spring 2021 Project Grant competition. Questions will be accepted via a Slido question board.
    Duration: 90 minutes
    English Sessions:
    When: Thursday, February 4, 2021 at 15:00 pm ET 
    When: Friday, February 5, 2021 at 13:00 pm ET 
    French Session
    When: Wednesday, February 3, 2021 at 11:00 am ET -

  • CIHR/SickKids Foundation: New Investigator Grants in Child and Youth Health, New Investigator Grants provide important early career development support to child health researchers. The competition is open to early career investigators from any CIHR eligible institution, who may apply for up to 3 years' support for research in biomedical, clinical, health systems and services, population and public health sectors. Another key support for these investigators has been CIHR’s decision to temporarily "pause the clock” for early career researchers, extending eligibility for one additional year, which also applies to this partnered competition. The maximum amount for a single grant is $300,000 ($100,000 per year for up to 3 years). Deadline for applications: April 20, 2021.

  • National Institutes of Health - Funding AnnouncementsThe National Institutes of Health has released these requests for applications and program announcements.

  • Human Frontiers Science Program - Research Grant Program. The Human Frontier Science Program (HFSP) supports innovative basic research that applies novel and interdisciplinary approaches to understand fundamental biological problems and includes scientific exchanges across national and disciplinary boundaries. Grants are for 3 years and made to international teams of 2 – 4 members who have not collaborated before. The amount is dependent upon team size, up to $465,000 per year for a team of four. UofT internal deadline: March 26, 2021: HFSP deadline for LOIs: March 30, 2021.

  • Canadian Asthma, Allergy and Immunology Foundation (CAAIF): Research And Fellowship Opportunities. 
    CAAIF Research Fellowship in Type 2 Inflammation supported by Sanofi Genzyme Canada, Duration: One Year: Amount: $75,000.
    Asthma Canada/CAAIF Graduate Student Awards. Duration: One year: Amount: $20,000.
    Deadline for submissions: April 26, 2021.

January 12, 2021

  • Temerty Knowledge Translation Grant: development of novel antibody tools for COVID-19 diagnosis or immunotherapies.  These grants are designed to support our researchers in translating fundamental science towards impactful applications in collaboration with a knowledge translation partner.
    Value: three thresholds of $25,000, $50,000, and $100,000 per award
    Duration: 1 year, with the possibility of an additional 1-year no-cost extension
    Application deadline: February 15th
    Eligibility: all Temerty Medicine faculty members can apply. A KT partner (e.g. clinical collaborator, industrial partner) must also be included.
    Application form for further details and submission process.
    Please note that this is the first in a series of Temerty Knowledge Translation Grants. Future calls will be open to any KT-oriented projects or focused on other emerging priority areas.

  • T-CAIREM Student Opportunities  T-CAIREM has announced two new programs to introduce U of T undergraduate and medical students to the field of AI in healthcare. T-CAIREM at the University of Toronto is an interdepartmental Centre that serves as a focal point for collaboration between computer scientists, healthcare providers, trainees, medical basic science researchers and industry to advance health through machine learning.
    - T-CAIREM 2021 Student Trainee Rounds
    Deadlines for Submissions: February 1, 2021
    - T-CAIREM 2021 Summer Research Studentship
    Application deadline: 5pm February 19, 2021

  • 2021 STAR Workshop Series: Spring Workshops   The Annual STrengthening Administration of Research (STAR) Conference has been transformed into a series of online workshops that will be held over the course of 2021. 
    Join your peers in expanding your knowledge on preparing for audits, the new procurement thresholds, research service vs. collaboration agreements, administering Canada Foundation for Innovation funds, the Tri-Agency Guide on Financial Administration, and more! 
    Workshop #1 - Research Administration Processes: The Impact of COVID-19 
    Thursday, January 28, 2021, 10:30-11:30am (Registration for Star Workshop #1)
    Presented by: 
    Donna Walker, Director, Research Financial Reporting & Audit, Research Oversight & Compliance, VPRI 
    Drew Gyorke, Director, Agency and Foundation Funding, Research Services VPRI
    Kevin Hamilton, Director, Institutional Initiatives, Research Services, VPRI 
    Workshop #2 - Research Procurement Updates
    Wednesday, Feb. 17, 2021 10:30 am – 11:30 am

    Presented by Nathan King, Senior Procurement Officer, Procurement Services
    (Register now for STAR workshop #2)

  • To kick start the New Year MITO2i is pleased to invite graduate students and post-doctoral working in all areas of mitochondrial research to participate in our fun and educational Science Communication Workshop and Video Competition. This exciting event will give trainees the chance to learn more about knowledge dissemination and how to effectively share their research to the general public. We are thrilled to announce that Ivan Semeniuk, Science Journalist for The Globe and Mail and who has previously worked for Nature, New Scientist Magazine and the Discovery Channel will be joining MITO2i on January 27th to host a workshop for trainees on science communication. This will be followed by a video tutorial workshop. More information on both workshops can be found below.Trainees will then have the opportunity to create there own 1 minute video describing their research in a fun and engaging way. Prizes will be awarded for the most innovative videos.To register for both workshops please click the links below:
    MitoFUTURES Workshop Series- Science Communication | Mitochondrial Innova (mito2i.ca)
    MitoFUTURES Workshop Series- Video Tutorial | Mitochondrial Innova (mito2i.ca) 

December 3, 2020

  • Cancer Research Society: Operating Grants.  The Operating Grants Program is the principal means by which the Cancer Research Society fulfills its mission to support fundamental, early translational and environment-cancer research in the broad field of cancer to contribute to the advancement of science aimed at preventing, detecting and treating this disease. The annual Cancer Research Society Operating Grants Competition is open to new and established researchers across Canada. Amount: $60,000 per year for two years.
    Deadlines for LOIs: December 9, 2020; Full application deadline: February 11, 2021.

  • CIHR Operating Grant: ECIs in Maternal, Reproductive, Child and Youth Health.  All applications in the area of maternal, reproductive, child and youth health research as per IHDCYH’s mandate will be eligible for support.In addition, funding is available to support projects that are determined to be relevant to the following specific research areas: Neurosciences, Mental Health and Addiction (INMHA): Maternal, reproductive, child and/or youth health research relevant to the Institute of Neurosciences, Mental Health and Addiction’s mandate to support research to enhance mental health, neurological health, vision, hearing, and cognitive function and to reduce the burden of related disorders through prevention strategies, screening, diagnosis, treatment, support systems, and palliation.

    In keeping with the CIHR Sex, Gender and Health Research policy, all proposals are expected to consider how sex and/or gender might shape the research described. Applicants are encouraged to visit the CIHR sex- and gender-based analysis resource page for more information on key considerations for the appropriate integration of sex and gender in their proposal. Deadline for registration: December 15, 2020; Application deadline: January 26, 2021.

  • CIHR's Policy on Identical and Essentially Identical Applications - What's New. This fall, CIHR aims to strengthen the research community’s awareness and understanding of the policy, and to that end, we would appreciate your help in promoting among your networks some recent developments.

  • Commercialization Grants – NSERC Idea to Innovation (I2I). Four times per year, the Natural Sciences and Engineering Research Council (NSERC) accepts applications for its “Idea to Innovation” (I2I) program, for the purpose of accelerating pre-competitive technologies for transfer to a Canadian company. Successful applicants receive awards of up to $125,000 for each phase of their commercialization project, with additional funding available as the project progresses. Internal Application Deadline for Current Round: Friday December 18th, 2020; Sponsor Deadline: Tuesday January 5th, 2021.

  • FRAXA Research Foundation: Fraxa Fellowships. FRAXA Research Foundation focuses on research which is likely to lead to new and improved treatments — and ultimately a cure — for Fragile X syndrome, with an emphasis on disease-modifying therapeutics based on understanding of Fragile X disease mechanisms. Every year we receive proposals from scientists worldwide seeking funding for the most cutting-edge Fragile X research. FRAXA Fellowships provide $45,000 USD per year for up to 2 years. Application deadline: February 1, 2021.

August 14, 2020

  • CIHR Fall 2020 and Spring 2021 Project Grant competitions: What's new for these competitions? CIHR has kept the key components of the program the same; however, there are a few changes that we want to bring to your attention. Some reflect the context of COVID-19, and all are designed to make the competition work better for all applicants and reviewers..
    -  Timelines shifted for Fall 2020 and Spring 2021 Project Grant competitions
    -  Additional page to highlight COVID-19-related impacts
    -  Expanded eligibility criteria to include Indigenous organizations
    -  Updated instructions around attaching previous reviews
    Deadlines for  Fall 2020 competition: Registration deadline: September 16, 2020, Application deadline: October 14, 2020.

  • PSI Graham Farquharson Knowledge Translation Fellowship 2021. This Fellowship is intended to provide salary support for a new Ontario investigator, who has demonstrated the ability to successfully complete high impact knowledge translation research. The Fellowship’s funds, dedicated to salary support, must protect at least 50% of the Fellow’s time to conduct such research. Please visit here to see elgibility criteria. All applications for this funding opportunity must be made through the Faculty of Medicine Research Office and are subject to internal review. All applications must include the completed PSIF application form and adhere to the guidelines provided. Only two applications will be selected for submission and formally endorsed by the institution. Electronic applications will be received by Cindy Fabeby Monday, September 28, 2020 at 9am.

March 17, 2020

  • EMHSeed Call for Proposals: Expanding research impact through inter-disciplinary collaboration. EXTENDED DEADLINE. The Joint EMHSeed and XSeed is an interdivisional research funding program designed to promote multi-disciplinary research and catalyze new innovative partnerships between a coPI from the Faculty of Applied Science and Engineering (FASE) and a coPI from outside Engineering. Partner divisions for EMHSeed: Faculty of Medicine (FoM), UofT Affiliated Hospitals, Medicine by Design (MbD), Translational Biology and Engineering Program (TBEP). The budget for each Seed project will be $60,000 CAD/year for two (2) years. In exceptional cases, a no-cost extension for an additional year will be considered. The $60,000 CAD/year amount for each project is the sum of total cash invested by each of the participating Faculties and departments/institutes. Deadline for proposals has been EXTENDED to: April 20, 2020.

  • NSERC Alliance Grants Workshop – Postponed. In compliance with guidelines restricting non-essential travel due to concerns over containment of COVID-19, NSERC, the Natural Sciences and Engineering Research Council, has postponed the on-campus visit to discuss the new NSERC-Alliance grant program, previously scheduled for April 8, 2020. The visit and workshop will be rescheduled later this year, and an announcement regarding the revised date will be made once such restrictions are lifted. In the meantime, the Innovations & Partnerships Office will continue to collect your questions; these questions will continue to be relayed to NSERC as appropriate for timely answers. Please continue to use “NSERC Alliance Question” as the email title, and send it to Colin Swift, Business Development Officer – Industry Partnerships. For more information about the NSERC Alliance program, please visit here.

  • On March 19th MROL moves to My Research Portal. Beginning March 19th, the link to My Research On-Line (MROL) will be removed and all users will access MROL via the My Research portal. This consolidation will streamline access to the system, and is part of the U of T Enterprise Modernization Program. Details on how to access My Research On Line (MROL) can be found here.

  • Physician's Services Inc. (PSI) Foundation: COVID-19 Research Stream. PSI Foundation invites all eligible clinician researchers to apply for this special funding stream. PSI will fast-track the processing of COVID-19 applications and aim for full review at our June 2020 Grants Committee meeting. Please submit your applications as soon as possible.